In a filing, Ionis Pharmaceuticals Inc revealed its Chief Executive Officer Monia Brett P unloaded Company’s shares for reported $4525.0 on Mar 11 ’25. In the deal valued at $32.32 per share,140 shares were sold. As a result of this transaction, Monia Brett P now holds 180,980 shares worth roughly $4.99 million.
Then, Monia Brett P bought 140 shares, generating $4,525 in total proceeds.
Before that, O’NEIL PATRICK R. sold 1,207 shares. Ionis Pharmaceuticals Inc shares valued at $39,046 were divested by the EVP CLO & General Counsel at a price of $32.35 per share. As a result of the transaction, O’NEIL PATRICK R. now holds 56,245 shares, worth roughly $1.55 million.
H.C. Wainwright initiated its Ionis Pharmaceuticals Inc [IONS] rating to a Buy in a research note published on April 07, 2025; the price target was $45. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in late March with a ‘”a Neutral”‘ rating. BMO Capital Markets also remained covering IONS and has decreased its forecast on August 02, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Leerink Partners revised its rating on July 24, 2024. It rated IONS as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of IONS
On Monday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock jump 1.77% to $27.57. Over the last five days, the stock has lost -8.62%. Ionis Pharmaceuticals Inc shares have fallen nearly -21.14% since the year began. Nevertheless, the stocks have fallen -35.63% over the past one year. While a 52-week high of $52.34 was reached on 01/02/25, a 52-week low of $26.88 was recorded on 04/07/25. SMA at 50 days reached $31.98, while 200 days put it at $38.95.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 26.19, which if violated will result in even more drops to 24.81. On the upside, there is a resistance level at 28.28. A further resistance level may holdings at 28.99. The Relative Strength Index (RSI) on the 14-day chart is 34.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.87, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.12%. Stochastics %K at 15.83% indicates the stock is a buying.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-03-14, growing by 0.14 million shares to a total of 12.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 12.67 million shares. There was a rise of 1.1%, which implies that there is a positive sentiment for the stock.
